MDFA News

New Nutrition Guidelines for AMD

Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD

Back

Most recent

Images showing a head and shoulders shot of an old man in a black tshirt smiling at the camera.

Switching should be allowed

With a new treatment for wet AMD coming on the market, drug switching between Lucentis and Eylea should be allowed.

Focus on families

Research has revealed Australians significantly underestimate the role of family history in developing macular degeneration.

Federal Budget reassuring

Macular Degeneration Foundation believes a cap on the Medicare item number for the treatment of wet AMD should have minimal impact on patients.

TGA approves Eylea

The TGA has approved a new drug, Eylea, for the treatment of wet (neovascular) age-related macular degeneration.

Audio description trial

ABC to trial audio description on television to assist people who are blind or visually impaired.

Judi Dench shares AMD diagnosis

Dame Judi Dench has revealed a diagnosis of age-related macular degeneration.

Postcard campaign success

The federal government has heard and acknowledged the Foundation’s postcard campaign for increased funding.

Image of older guy holding a pair of glasses and looking thoughtfully at the camera

CATT study raises questions

We reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.

image of test tubes in research laboratory

Inaugural research grants awarded

The inaugural Macular Degeneration Foundation Research Grants Program awarded nearly three-quarters of a million dollars to support crucial macular disease research.

MDFA News

New Nutrition Guidelines for AMD

Most recent

Switching should be allowed

Focus on families

Federal Budget reassuring

TGA approves Eylea

Audio description trial

Judi Dench shares AMD diagnosis

Postcard campaign success

CATT study raises questions

Inaugural research grants awarded

Follow us

Newsletter sign-up

Thank you.
Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

There are no items to display.

Please broaden your search.

MDFA News

New Nutrition Guidelines for AMD

Most recent

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

There are no items to display.

Please broaden your search.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters: